AML patients with higher expression of GPX4 (above median) were associated with lower overall survival in comparison to those with lower expression of GPX4 (below median) based on GSE1729 (Fig. 1J) and TCGA database (Fig. 1K). The gene discussed is GPX4; the disease is acute myeloid leukemia.